アプタマー市場レポート：タイプ、用途、地域別、2024～2032年

世界のアプタマー市場規模は2023年に26億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに118億米ドルに達し、2024～2032年の間に17.8%の成長率（CAGR）を示すと予測しています。

アプタマーは、タンパク質、ペプチド、炭水化物、低分子、毒素、生きた細胞など、特定の対象に結合する汎用性の高いオリゴヌクレオチドです。オリゴヌクレオチドは修飾可能で、免疫原性がなく、感度が高く、毒性が低く、調製が容易で、低分子量であり、抗体と比較して調製の違いによるばらつきがないです。その結果、治療やバイオテクノロジーのセグメントで広く利用されています。また、研究用薬剤、診断薬、バイオセンサー、バイオマーカーや創薬のツールとしても世界中で利用されています。

世界のアプタマー市場動向

がん、神経変性疾患、心血管疾患、後天性免疫不全症候群（AIDS）など、生命を脅かす疾患の蔓延が拡大していることは、アプタマー療法別の新規で効果的な検出アッセイの需要に影響を与える重要な要因の一つです。さらに、ヌクレアーゼ耐性を高め、アプタマーの治療特性を向上させる化学修飾プロセスの出現が、市場の成長を後押ししています。アプタマー市場の成長は、診断機器や医薬品、そのキャリアを改良するために行われる研究開発（R&D）活動の増加にも起因しています。これとは別に、アプタマーは化学的に合成されるため、バッチ間のばらつきがなく、開発に要する時間が短いことから、その応用は世界中で広く拡大しています。さらに、民間企業は学術機関や研究所と協力して次世代製品を導入し、既存の市場でのプレゼンスを拡大しようとしています。このため、幅広い医療療法や飲食品（F&B）業界におけるアプタマーの利用が促進されると予想されます。

本レポートで扱う主要質問

• 世界のアプタマー市場はこれまでどのように推移し、今後どのように推移するのか？
• COVID-19は世界のアプタマー市場にどのような影響を与えたか？
• 主要地域市場とは？
• タイプ別の市場内訳は？
• 用途別の市場内訳は？
• 業界のバリューチェーンにおける様々な段階とは？
• 業界の主要な促進要因と課題は何か？
• 世界のアプタマー市場の構造と主要参入企業は？
• 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界のアプタマー市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：タイプ別

• 核酸
• ペプチド

第7章 市場内訳：用途別

• 診断
• 治療
• 研究開発
• その他

第8章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第9章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第12章 価格分析

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Aptagen LLC
  • Aptamer Group
  • Aptamer Sciences Inc.
  • Aptus Biotech S.L.
  • Base Pair Biotechnologies Inc.
  • IBA GmbH
  • Kaneka Eurogentec S.A.（Kaneka Corporation）
  • NeoVentures Biotechnology Inc.
  • NOXXON Pharma
  • SomaLogic Inc.
  • TriLink BioTechnologies LLC
  • Vivonics Inc.

List of Figures

• Figure 1: Global: Aptamers Market: Major Drivers and Challenges
• Figure 2: Global: Aptamers Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Aptamers Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Aptamers Market: Breakup by Type (in %), 2023
• Figure 5: Global: Aptamers Market: Breakup by Application (in %), 2023
• Figure 6: Global: Aptamers Market: Breakup by Region (in %), 2023
• Figure 7: Global: Aptamers (Nucleic Acid) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 8: Global: Aptamers (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 9: Global: Aptamers (Peptide) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 10: Global: Aptamers (Peptide) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 11: Global: Aptamers (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 12: Global: Aptamers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 13: Global: Aptamers (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 14: Global: Aptamers (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 15: Global: Aptamers (Research and Developments) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 16: Global: Aptamers (Research and Developments) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 17: Global: Aptamers (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 18: Global: Aptamers (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 19: North America: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 20: North America: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 21: United States: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 22: United States: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 23: Canada: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 24: Canada: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 25: Asia-Pacific: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 26: Asia-Pacific: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 27: China: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 28: China: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 29: Japan: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 30: Japan: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 31: India: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 32: India: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 33: South Korea: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 34: South Korea: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 35: Australia: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 36: Australia: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 37: Indonesia: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 38: Indonesia: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 39: Others: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 40: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 41: Europe: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 42: Europe: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 43: Germany: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 44: Germany: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 45: France: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 46: France: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 47: United Kingdom: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 48: United Kingdom: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 49: Italy: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 50: Italy: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 51: Spain: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 52: Spain: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 53: Russia: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 54: Russia: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 55: Others: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 56: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 57: Latin America: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 58: Latin America: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 59: Brazil: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 60: Brazil: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 61: Mexico: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 62: Mexico: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 63: Others: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 64: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 65: Middle East and Africa: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
• Figure 66: Middle East and Africa: Aptamers Market: Breakup by Country (in %), 2023
• Figure 67: Middle East and Africa: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 68: Global: Aptamers Industry: SWOT Analysis
• Figure 69: Global: Aptamers Industry: Value Chain Analysis
• Figure 70: Global: Aptamers Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Aptamers Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Aptamers Market Forecast: Breakup by Type (in Million US$), 2024-2032
• Table 3: Global: Aptamers Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 4: Global: Aptamers Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 5: Global: Aptamers Market: Competitive Structure
• Table 6: Global: Aptamers Market: Key Players

The global aptamers market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 17.8% during 2024-2032.

Aptamers are versatile oligonucleotides that bind to a specific target, including proteins, peptides, carbohydrates, small molecules, toxins, and live cells. They are modifiable, nonimmunogenic, highly sensitive, less toxic, easy to prepare and have low molecular weight and no variation with different preparations as compared to antibodies. As a result, they are widely being used in therapeutic and biotechnological applications. Besides this, they are also utilized as research agents, diagnostics, biosensors, and tools for biomarker or drug discovery worldwide.

Global Aptamers Market Trends:

The growing prevalence of life-threatening diseases, such as cancer, neurodegenerative, cardiovascular, and acquired immunodeficiency syndrome (AIDS), represents one of the key factors influencing the demand for new and effective detection assays based on aptamer therapy. Moreover, the advent of the chemical modification process to increase the nuclease resistance and enhance the therapeutic properties of aptamers is bolstering the market growth. The aptamers market growth can also be accredited to the rising number of research and development (R&D) activities undertaken for improving diagnostic devices and drugs and their carriers. Apart from this, as aptamers are chemically synthesized, which eliminates batch-to-batch variation and requires less time for development, their application is extensively increasing across the globe. Furthermore, private organizations are collaborating with academic institutes and research laboratories to introduce next-generation products and expand their existing market presence. This is anticipated to fuel the usage of aptamers in a wide range of medical therapies, as well as in the food and beverage (F&B) industry.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global aptamers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type and application.

Breakup by Type:

Nucleic Acid

Peptide

Breakup by Application:

Diagnostics

Therapeutics

Research and Developments

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aptagen LLC, Aptamer Group, Aptamer Sciences Inc., Aptus Biotech S.L., Base Pair Biotechnologies Inc., IBA GmbH, Kaneka Eurogentec S.A. (Kaneka Corporation), NeoVentures Biotechnology Inc., NOXXON Pharma, SomaLogic Inc., TriLink BioTechnologies LLC and Vivonics Inc.

Key Questions Answered in This Report:

• How has the global aptamers market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global aptamers market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the application?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global aptamers market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Aptamers Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Nucleic Acid
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Peptide
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Application

• 7.1 Diagnostics
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Therapeutics
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Research and Developments
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Aptagen LLC
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Aptamer Group
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Aptamer Sciences Inc.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Aptus Biotech S.L.
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
  • 13.3.5 Base Pair Biotechnologies Inc.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
  • 13.3.6 IBA GmbH
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
  • 13.3.7 Kaneka Eurogentec S.A. (Kaneka Corporation)
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
  • 13.3.8 NeoVentures Biotechnology Inc.
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 NOXXON Pharma
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
  • 13.3.10 SomaLogic Inc.
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
  • 13.3.11 TriLink BioTechnologies LLC
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
  • 13.3.12 Vivonics Inc.
    • 13.3.12.1 Company Overview
    • 13.3.12.2 Product Portfolio